Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: A retrospective study

Pei Yi Chou, Meng Hsing Wu, Hsien An Pan, Kuei Hsiang Hung, Fong Ming Chang

研究成果: Article同行評審

23 引文 斯高帕斯(Scopus)

摘要

Objective: This retrospective study aimed to investigate the use of an oxytocin antagonist in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). Materials and Methods: A total of 150 infertile couples with RIF undergoing IVF-ET were divided into three groups. Patients who did not receive atosiban were used as controls (Group 1; n= 80). Forty patients received a single bolus dose (6.75 mg, 0.9. mL/vial) of atosiban before ET (Group 2), and 30 patients received a bolus dose of 6.75 mg atosiban followed by infusion at 18 mg/hr for 3 hours immediately after ET (Group 3). Results: A significantly higher implantation rate (30.21%) was noted in Group 2 compared with Groups 1 and 3 (11.8% and 15.9%, respectively; p= 0.0006). The clinical pregnancy rate of Group 2 (37.5%) was significantly higher than that of Groups 1 (12.5%) and 3 (20%) (p= 0.0057). The live birth rate was significantly higher in Group 2 (35%) than in Groups 1 and 3 (10% and 16.67%, respectively; p= 0.0031). Conclusion: These results suggest that IVF-ET using lower dosage of atosiban may improve pregnancy outcomes of patients with RIF.

原文English
頁(從 - 到)136-140
頁數5
期刊Taiwanese Journal of Obstetrics and Gynecology
50
發行號2
DOIs
出版狀態Published - 2011 六月

All Science Journal Classification (ASJC) codes

  • 婦產科

指紋

深入研究「Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: A retrospective study」主題。共同形成了獨特的指紋。

引用此